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Background: Warfarin is the oral anticoagulant that is most commonly used to control 
and prevent thromboembolic disorders. It requires meticulous testing and dosing 
adjustments to attain therapeutic international normalized ratio (INR) levels. Patient self-
testing (PST) is associated with a reduced risk of all-cause mortality and lower rates of 
thromboembolism and bleeding. PST meters offers convenience and promotes self-
initiative of care.  
 
Purpose: The purpose of the project is to evaluate the effectiveness of INR PST in adult 
patients diagnosed with atrial fibrillation, deep vein thrombosis, and mechanical heart 
valve on warfarin therapy in a Cardiology practice compared to traditional laboratory 
methods, or usual care.  
 
Description of Design: Chart reviews were conducted to identify patients on warfarin 
(for greater than six months) with the medical indication of atrial fibrillation, deep vein 
thrombosis, and mechanical heart valve. Data obtained from medical records included 
INR lab values, age, gender, medical indication, method of testing, and insurance carrier. 
INR lab values were analyzed over a four-year time period (August 2010 – August 2014) 
for control of INRs based on method of testing. 
 
Outcomes: Pre- and post- data reveal patients had tighter INR control after PST 
initiation. A statistically significant trend is noted at the three-month point from date of 
initiation, where the group experienced less therapeutic control, however control of INRs 
continued to be tighter compared to usual care.  
 
Statement of Conclusions: The data suggests adult patients on warfarin utilizing PST 
method of INR testing showed tighter control of INRs as compared to usual care. 
 
Implications for practice: Based on the data obtained, the six months following the 
three month PST initiation suggested provider follow-up after three months of initiation 






Background & Evidence for problem 
Warfarin is the oral anticoagulant that is most commonly used to control and 
prevent thromboembolic disorders.  According to the Joint Commission improper 
monitoring of anticoagulants resulted in loss of function and deaths in 26% of the nation. 
Warfarin is a medication that requires meticulous testing and dosing adjustments to attain 
therapeutic International Normalized Ration (INR) levels.   An INR level is a crucial 
laboratory measurement to make certain the blood will not put the patient at risk for 
bleeding or clotting. The goal of warfarin management is to administer a therapeutic dose 
to provide the patient protection against clotting conditions and minimizing the risk of 
bleeding. Signs of warfarin overtreatment are increased bruising, excessive bleeding, and 
presence of blood in stool and emesis.  The increase danger of bleeding further 
complicates safety awareness in older patients.  Under treatment may increase the risk for 
blood clots, which may dislodge into small arteries in the brain or heart causing stroke or 
myocardial infarction. Challenges of usual laboratory testing are time and scheduling 
inconveniences, separate visits for blood draw and result interpretation, possible return to 
the lab for system error, therefore possible delay in treatment, multiple medical 
consultations, and lack of independence.  
The main challenge observed in this cardiology practice has been an increase of 
patients on warfarin who have acquired complications from non-therapeutic INR’s and 
required immediate intervention including hospitalization.  
Evidence-based intervention  
The intended population in this a cardiology clinic are adults who are currently 
receiving warfarin management. The utilization of patient-self testing (PST) is the 




is just as accurate as conventional laboratory methods (Garcia-Alamino et al., 2012). The 
PST is a portable device allowing convenience of INR testing in the comfort of the 
patients’ own home.  The meter is very similar to glucometers used for diabetic patients. 
A sample of blood is collected from a fingerstick using a lancet. The test strip is inserted 
into the pocket-sized device and blood is dropped on to the strip. The result is available 
immediately. The device works by measuring thromboplastin-mediated clotting time, 
then converted to plasma PT and expressed as an INR value.  The health care provider 
will receive the INR reports from the meter vendor providing PST service as results 
become available. 
 PST would allow for more frequent monitoring, better treatment adherence, and 
fewer thromboembolic or hemorrhagic complications (Heneghan, 2012). An estimated 
19,380 strokes and 916 bleeds would be prevented each year by home INR testing (Caro, 
2004).  “A conservative economic model estimated a Medicare savings of $1.14 billion 
annually through maintaining patients eligible for anticoagulation on therapeutic doses of 
warfarin” (Caro, 2004). 
Evidence of Accuracy in Patient Care Settings 
There is strong evidence that PST meters are just as accurate as laboratory 
findings and are effective to utilize in practice. In a systematic review by Christensen & 
Larsen (2012), analyzing 22 randomized control studies, PST meters were found to have 
adequate precision in the clinical setting. A randomized control trial conducted by 
Sobieral-Teague, Daniel, Farelly, Coghlan, and Gallus monitored daily INR until INRs 
were “2.0” for two consecutive readings. The purpose of this study was to determine 




devices from the same manufacturer and compared them to traditional methods. Nearly 
all (99.4%) of PST INR’s were within 0.8 units of laboratory INR’s (Sobieral-Teague, 
Daniel, Farelly, Coghlan, & Gallus, 2009).  
In another randomized control trial study performed by Donaldson, Sullivan, and 
Norbeck in 2010, two point-of-care devices were compared with laboratory methods. 
INR’S of 52 patients receiving oral Warfarin therapy were measured using both devices 
and during the same visit a blood sample was taken from each patient for lab analysis. 
Values from PST meters and laboratory were within 0.4 units of each other 67% of the 
time (Donaldson, Sullivan, & Norbeck, 2010).  
Bardacki et al. studied 105 patients undergoing open-heart surgery for mechanical 
valve replacements. Patients were placed on vitamin k antagonists along with low 
molecular weight heparin. Patient-self test and laboratory techniques were used to obtain 
INR results daily after surgery until therapeutic INR range was achieved. INR values 




 postoperative days (Bardaki et al., 
2013). Testing occurred daily, using both methods and resulted in similar results.  
Evidence of Improved INR Maintenance and Reductions in Bleeding Complications  
A systematic review evaluated by Garcia-Alamino et al. (2012) examined effects 
of self-monitoring and self-management of oral anticoagulant therapy and compared 
results to standard monitoring. The Cochran Central Register of Controlled Trials, 
MEDLINE, EMBASE, and CINAHL were databases used to search for 18 randomized 
trials, incorporating a total of 4,723 participants.  Twelve out of 18 trials reported 
improvement in percentage of mean INR measurements in therapeutic range (Garcia-




significant reductions in thromboembolic events and all-cause mortalty; reduced major 
hemorrhages” (Garcia-Alamino, et al., 2012, p.2).   
Heneghan et al. completed a  large meta-analysis of 11 randomized control trials 
consists of 6,417 adults and analyzed the effect of self-monitoring or self-management 
versus standard monitoring on thromboembolic events, major bleeding, and mortality as 
well as measurements within therapeutic range. Searches were limited to EMBASE 
(1980-2009) and MEDLINE (1966-2009).  The review indicated a 55% reduction in 
thromboembolic events, 35% reduction in bleeding, and a 39% reduction in all-cause 
mortality (Heneghan, Ward, Perera, & the Self-monitoring Trial Collaboration, 2012).  
Heneghan et al. also found improvements on INR measurements within therapeutic range 
in patients that were self-monitoring.  
Implementation 
 
The purpose of the project is to evaluate the effectiveness of INR PST in adult 
patients diagnosed with atrial fibrillation, deep vein thrombosis, and mechanical heart 
valve on warfarin therapy in a Cardiology practice compared to traditional laboratory 
methods, or usual care. The selection of patients to participate in this study was provided 
by the practice and gathered by a computer generated list using the ICD-9 code for 
patients on anticoagulant therapy. Data were obtained from two groups of patients on oral 
warfarin: 1) patients testing INR’s levels via usual care and 2) patients currently utilizing 
PST meters. The practice had 13 patients on PST meters. Inclusion criteria include 
warfarin therapy for six months or longer, diagnosis of atrial fibrillation, mechanical 
heart valve, and/or history of deep vein thrombosis. All data were obtained from medical 




(August 2010-Agust 2014), including INR lab values, age, gender, medical indication, 
method of testing, and insurance carrier.  
Although 4 years of data was collected, three phases of PST monitoring were 
identified. The three phases of PST monitoring that were closely evaluated were: six 
months prior to initiation of PST, the first three months of initiation of PST, and the last 
six months following the three month initiation. All INR data were documented into the 
patient chart, regardless of testing method, either usual care or PST meters. 
Evaluation Results  
 
 





Figure 2. Consistency of INR values Pre- Post- PST 
The PST patient population included 13 patients, 10 over the age of 65 with ten 
male patients and three female patients.  There were eight patients with the diagnosis 
atrial fibrillation (afib), two patients with diagnosis of deep vein thrombosis (DVT), one 
patient with both afib and DVT, and two with mechanical heart valves.  
INR lab values were analyzed over a four-year time period (August 2010 – 
August 2014) for control of INRs based on method of testing. A X bar (Figure 1) and R 
(Figure 2) control chart were created using QI Macros software to evaluate the INR 
values over the total number of patients, thereby controlling for volume. The X bar 
indicates INR values averages for the group for the four-year period (August 2010 – 
August 2014). The break in values (see red arrows), indicate initiation of PST. The 
control limits for the data values before the break have a wider control, which means 




PST initiation shows a much narrower control, which means data values was less variable 
and tighter control of INR levels. However, the data values after the three-month 
initiation period (purple arrows) show increase and wider control once again. The PST 
group experienced less therapeutic control, however control of INRs continued to be 
tighter compared to usual care. 
Figure 2 provides information about how consistent the INR values are among the 
group. The red data points seen in the R control chart indicate statistically significant, 
undesirable trend showing lessening of therapeutic control, or more variation among 
values.  The red data points are observed outside of the control limits.  
Figure 3.  PST group’s Pre-Post Implementation Percent in Therapeutic Range  
In Figure 3, the PST group, showed excellent control within the first three months 
of initiation. After the three-month adjustment period, monitoring was not as frequent and 
resulting in less control. One patient was not testing frequently pre-PST and post-PST. 




patients, their post- PST results were worse than their pre-PST results. The groups’ INR 
average percentage in therapeutic range Pre-PST was approximately 53% and Post-PST 
was approximately 58%.  
Figure 3.  Percent in therapeutic range of usual care patients.  
Patients in the usual care group had unpredictable and varying INR values. There 
were no specific patterns observed. INR’s were tested at least monthly. These patients 
were in therapeutic range approximately 50% of the time.   
Cost Implications 
 There were no extra costs spent by the practice prior to implementation. Medicare 
remains the top insurer for adults in this population. Fortunately, Medicare covers PST 
meters for patients, reimburses the practice for the initial PST education prior to 












































According to the evidence, PST meters are an effective INR evaluation method 
and preventing clotting and bleeding complications from warfarin. The usual care group 
showed fluctuations in INR data and exhibited lack of consistency in therapeutic range. 
This study revealed tighter control in the PST group after initiation of meters. There was 
an undesirable trend observed through data collection after the three-month initiation 
period, which suggests need for follow-up intervention.  
Implications for Clinical Practice and Sustainability 
 
PST INR testing method is easily sustainable in this practice setting. Appropriate 
provider follow-up and support are the foundations of successful patient outcomes for 
patient self-testing. This study suggests a three month follow-up visit may be needed to 
reinforce testing frequency and compliance. During this visit it is crucial to identify and 
correct any possible barriers to testing.  
Discussion 
 
New anticoagulants have recently been introduced as an alternative to warfarin. 
These medications do not require close monitoring with INR testing, provide 
convenience of standard dosing, and have fewer bleeding and stroke risks (Buller et al., 
2013). Examples of these medications are clopidogrel, ticagrelor, rivaroxaban, and 
edoxaban. 
The Rocket AF trial compared effectiveness of rivaroxaban and warfarin to 
prevent stroke or systemic embolism in patients with nonvalvular atrial fibrillation. 
Rivaroxaban proved less frequent intracranial and fatal bleeding than warfarin and 




0.001). Edoxaban is a newer anticoagulant in the same pharmaceutical category. It is 
primarily given to prevent venous thromboembolism. In a study by Buller et al., 
Edoxaban resulted in 3.3% rate of recurrent venous thromboembolism while warfarin 
resulted in 6.2% recurrence rate. 
The PLATO study compared ticagrelor to clopidogrel to determine superiority on 
prevention of vascular events and death in patients with an acute coronary syndrome. 
The study resulted in a significantly reduced rate of death from vascular causes, 
myocardial infarction or stoke without an increase in rate of major bleeding for patients 
taking ticagrelor. (CITE) 
 Warfarin is a sensitive medication that requires meticulous management to 
prevent adverse complications. With the development and release of newer anticoagulant 
medications, warfarin may be used less. In the meantime, INR monitoring while on 
warfarin remains to be a crucial aspect of care. PST meters have been proven to be as 
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Background: Warfarin is the oral anticoagulant that is most commonly used to control 
and prevent thromboembolic disorders, it requires meticulous testing and dosing 
adjustments to attain therapeutic international normalized ratio (INR) levels. High rates 
of patients in non-therapeutic INR ranges are generally caused by failure of the provider 
to adjust INR doses based on monitoring. Patient self-testing (PST) is associated with a 
reduced risk of all-cause mortality and lower rates of thromboembolism and bleeding. 
PST meters offers convenience and promotes self-initiative of care.  
 
Purpose: The purpose of the project is to evaluate the effectiveness of INR PST in adult 
patients diagnosed with atrial fibrillation, deep vein thrombosis, and mechanical heart 
valve on warfarin therapy in a Cardiology practice compared to traditional laboratory 
methods, or usual care.  
 
Description of Design: Chart reviews were conducted to identify patients on warfarin 
(for greater than six months) in the practice with the medical indication of atrial 
fibrillation, deep vein thrombosis, and mechanical heart valve. Data obtained from 
medical records included INR lab values, age, gender, medical indication, method of 
testing, and insurance carrier. INR lab values were analyzed over a four-year time period 
(August 2010 – August 2014) for control of INRs based on method of testing. 
 
Outcomes: Pre- and post- data reveal patients on warfarin had tighter INR control after 
PST initiation. A statistically significant trend is noted at the three-month point from date 
of initiation, where the group experienced less therapeutic control, however control of 
INRs continued to be tighter compared to usual care.  
 
Statement of Conclusions: The data suggests adult patients on warfarin utilizing PST 
method of INR testing showed tighter control of INRs as compared to usual care. 
 
Implications for practice: Appropriate provider follow-up and support are the 
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